These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28502135)

  • 1. Systemic Lupus Erythmatosus is Associated with Disturbed Cytokine Milieu and Increased TNF-Related Apoptosis-Induced Ligand Levels.
    Saeed AM; Mogahed MM
    Egypt J Immunol; 2016 Jun; 23(2):75-85. PubMed ID: 28502135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.
    Lub-de Hooge MN; de Vries EG; de Jong S; Bijl M
    Ann Rheum Dis; 2005 Jun; 64(6):854-8. PubMed ID: 15564310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity.
    Sabry A; Sheashaa H; El-Husseini A; Mahmoud K; Eldahshan KF; George SK; Abdel-Khalek E; El-Shafey EM; Abo-Zenah H
    Cytokine; 2006 Aug; 35(3-4):148-53. PubMed ID: 17027280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression and release of functional tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by T cells from lupus patients with active disease.
    Rus V; Zernetkina V; Puliaev R; Cudrici C; Mathai S; Via CS
    Clin Immunol; 2005 Oct; 117(1):48-56. PubMed ID: 15961346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T; Fierz W; Stoll T; Villiger PM
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus.
    Liphaus BL; Kiss MHB; Carrasco S; Palmeira P; Goldenstein-Schainberg C; Carneiro-Sampaio M
    Clin Rheumatol; 2017 Dec; 36(12):2847-2852. PubMed ID: 28378099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?
    Gómez D; Correa PA; Gómez LM; Cadena J; Molina JF; Anaya JM
    Semin Arthritis Rheum; 2004 Jun; 33(6):404-13. PubMed ID: 15190525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of p53 with other oncogenes, cytokines and systemic lupus erythematosus activity.
    Miret C; Molina R; Filella X; García-Carrasco M; Claver G; Ingelmo M; Ballesta A; Font J
    Tumour Biol; 2003; 24(4):185-8. PubMed ID: 14654712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between levels of TNF-alpha and IL-6 and hematological involvement in SLE Egyptian patients with lupus nephritis.
    Sabry A; Elbasyouni SR; Sheashaa HA; Alhusseini AA; Mahmoud K; George SK; Kaleek EA; abo-Zena H; Kalil AM; Mohsen T; Rahim MA; El-samanody AZ
    Int Urol Nephrol; 2006; 38(3-4):731-7. PubMed ID: 17260180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus.
    Studnicka-Benke A; Steiner G; Petera P; Smolen JS
    Br J Rheumatol; 1996 Nov; 35(11):1067-74. PubMed ID: 8948291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjects.
    Arora V; Verma J; Marwah V; Kumar A; Anand D; Das N
    Lupus; 2012 May; 21(6):596-603. PubMed ID: 22300832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of anti-CD4 antibodies on the release of IL-6 and TNF-alpha in whole blood samples from patients with systemic lupus erythematosus.
    Brink I; Thiele B; Burmester GR; Trebeljahr G; Emmrich F; Hiepe F
    Lupus; 1999; 8(9):723-30. PubMed ID: 10602444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.
    Robak E; Sysa-Jedrzejewska A; Dziankowska B; Torzecka D; Chojnowski K; Robak T
    Arch Immunol Ther Exp (Warsz); 1998; 46(6):375-80. PubMed ID: 9883317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
    Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients.
    McCarthy EM; Smith S; Lee RZ; Cunnane G; Doran MF; Donnelly S; Howard D; O'Connell P; Kearns G; Ní Gabhann J; Jefferies CA
    Rheumatology (Oxford); 2014 Sep; 53(9):1586-94. PubMed ID: 24706988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus.
    Gattorno M; Vignola S; Barbano G; Sormani MP; Sabatini F; Buoncompagni A; Picco P; Pistoia V
    J Rheumatol; 2000 Sep; 27(9):2251-5. PubMed ID: 10990243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine profiling in active and quiescent SLE reveals distinct patient subpopulations.
    Reynolds JA; McCarthy EM; Haque S; Ngamjanyaporn P; Sergeant JC; Lee E; Lee E; Kilfeather SA; Parker B; Bruce IN
    Arthritis Res Ther; 2018 Aug; 20(1):173. PubMed ID: 30092845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up regulation of serum tumor necrosis factor-related apoptosis inducing ligand in juvenile-onset systemic lupus erythematosus: relations with disease activity, antibodies to double -stranded DNA, nephritis and neutropenia.
    Ezzat MH; El-Gammasy TM; Shaheen KY; El-Mezdawi RA; Youssef MS
    Int J Rheum Dis; 2013 Jun; 16(3):310-8. PubMed ID: 23981753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proinflammatory cytokines in inactive lupus erythematosus patients].
    Lesiak A; Sysa-Jedrzejowska A; Narbutt J; Lukamowicz J; Robak E; Wozniacka A
    Przegl Lek; 2005; 62(9):838-42. PubMed ID: 16541713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.